HCW Biologics is trading 6.01% up at $2.17 after-hours, without a confirmed catalyst.
- It closed September 15, 2026, at $2.05 after a 6.82% regular-session decline.
- No new company-specific announcement or earnings release was identified that day; the latest notable news was the September 8 distribution agreement with Akron Biotech.
- Broader markets were risk-off on September 15, 2026, reducing confidence in a macro explanation.